Role of P-glycoprotein in transplacental transfer of methadone
about
Opioid dependency in pregnancy and length of stay for neonatal abstinence syndromeThe effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancyATP-binding cassette efflux transporters in human placenta.Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.In vitro placental model optimization for nanoparticle transport studies.P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study.Opioid dependent and pregnant: what are the best options for mothers and neonates?Drug Interactions at the Human Placenta: What is the Evidence?Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences†.Pharmacogenetics of chronic pain and its treatment.Interindividual variability of methadone response: impact of genetic polymorphism.Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast.The impact of cocaine and heroin on the placental transfer of methadone.Opiates inhibit paclitaxel uptake by P-glycoprotein in preparations of human placental inside-out vesiclesDrug transporters in the human blood-placental barrier.ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison.Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents.Methadone: a review of drug-drug and pathophysiological interactions.Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer.Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain.Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2).Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.Transplacental exchange of moxidectin after maternal or fetal intravenous administration in sheep.Role of CYP3A5 in abnormal clearance of methadone.Taxanes during Pregnancy: Probably Safe, but Still to Be Optimized
P2860
Q24628765-6CA7BB91-7F1E-4731-AE1C-4A9D229212CFQ30490602-3381CF97-FCF4-45E2-A8EE-4E335E8571E4Q33833207-6E40A4A6-19E4-4DC5-9782-AC83B873BDF9Q34457456-30C635F0-5CFD-46D6-8A1D-6F8166F78943Q34843023-CF49F5AE-E327-4984-9D79-8DA073B53E32Q35000765-E14E492F-3679-4552-A3EC-2635C848022AQ35741053-CC45C4F3-211F-4889-BDC9-020F22753E71Q35802617-890EC2D0-BB36-4AA7-A216-C577F73B0156Q35837987-F6FB309C-FA8C-4430-B7C7-F73121D73876Q36081992-D308CA9F-DBDD-4864-8DA4-F36C2F218874Q36107418-D93A9FF0-771E-4A93-9507-C2640F26DD7CQ36306228-524C612F-88BE-48AB-A70C-A0C74B8DF2E6Q36322293-750F7174-7F41-47D8-B136-511B5665A4CFQ36900075-C9BD7AB7-9B17-4CD0-9FF1-4156E1C5AE45Q37142009-AFF4D267-AAC8-4F17-8422-3B432A3B3F5CQ37158671-2500666F-F643-4847-B798-6ED047C266ECQ37244967-D30918BC-60C8-437F-991D-708F857B1899Q37356356-79A9B21E-2601-4599-9B46-85DD25229F01Q37395889-B75DF7FC-AA92-4A9B-8ECD-4F6004466AC3Q37782354-8BD88D61-5091-45BF-B8A8-D23391D27E72Q37830057-37C40353-BC57-4DC7-B17B-7E205139A105Q37950478-DAF5FDB5-B56C-4812-BE90-841FE2FD2831Q38044958-3C62F0EA-30BF-41D0-B4D6-1376372BAD5DQ38093852-143A7AE0-6822-4484-8CA1-51B71DFCDA26Q38478413-A9F5488C-3E9E-4293-8791-C6EB080242D5Q38791566-ADD37D59-B609-4D34-B068-245C420C044AQ38958745-D52B1ABF-3106-44CE-96EB-D2FF3A461B0EQ39285381-FF189DFF-7B04-424A-BFF3-9B9D2906AD94Q39779618-09C216A2-AC20-4467-87AE-5C2B1A60D065Q41987974-9B5542C0-3D8D-4A23-93EB-66F9F9DC4F2AQ43073550-809DE6BB-4370-41AB-8E23-DAFD9F4FF37CQ46609377-1D8400D6-EE0C-43E6-A4F9-1C65783D7CBBQ56068808-126B8688-6B32-4DD5-B556-498215C4F856
P2860
Role of P-glycoprotein in transplacental transfer of methadone
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Role of P-glycoprotein in transplacental transfer of methadone
@ast
Role of P-glycoprotein in transplacental transfer of methadone
@en
type
label
Role of P-glycoprotein in transplacental transfer of methadone
@ast
Role of P-glycoprotein in transplacental transfer of methadone
@en
prefLabel
Role of P-glycoprotein in transplacental transfer of methadone
@ast
Role of P-glycoprotein in transplacental transfer of methadone
@en
P2093
P2860
P1476
Role of P-glycoprotein in transplacental transfer of methadone
@en
P2093
Gary D V Hankins
Ilona Nekhayeva
Kenneth Audus
Mahmoud S Ahmed
Nedra Karunaratne
Tatiana Nanovskaya
P2860
P304
P356
10.1016/J.BCP.2005.03.030
P407
P577
2005-06-01T00:00:00Z